Episode notes
In Highlights and Hindsight in CLL, Dr. Matthew Davids will describe the most significant ongoing studies and publications in CLL from 2024 and will detail their impact on the treatment continuum. This activity will enable participants to stay updated on the most relevant breakthroughs and improve outcomes among patients.
Launch Date: December 18, 2024
Release Date: December 18, 2024
Expiration Date: November 30, 2025
FACULTY
Matthew Davids, MD, MMSc
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
This podcast provides accredited continuing education credits. To receive your credit,